Assessment of the economic evaluation of the contrast agent Iomeron in percutaneous coronary intervention
Percutaneous coronary intervention (PCI - angiography and stent placement) aren't possible without X-ray contrast agents. Contrast enhancement depends on the iodine concentration, while the safety of particular contrast agents diff ers. Th e aim of the study is to conduct health economic evalua...
Saved in:
Main Authors: | A. S. Kolbin (Author), I. A. Vilum (Author) |
---|---|
Format: | Book |
Published: |
Izdatelstvo OKI,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of the economic evaluation of the contrast agent MultiHance
by: A. S. Kolbin, et al.
Published: (2018) -
Assessment of the economic feasibility of gadoversetamida (OptiMARK) MRI with intravenous contrast
by: A. S. Kolbin, et al.
Published: (2018) -
Contrast-Induced Nephropathy in patients submitted to percutaneous coronary intervention: an integrative review
by: Matheus Santos Moitinho, et al. -
Overconsumption of Contrast Media in Percutaneous Coronary Intervention: Focusing on Cost and Acute Kidney Injury
by: Marziye Jafari, et al.
Published: (2019) -
The Effects of Pentoxifylline on Contrast-induced Nephropathy Reduction in Patients Undergoing Percutaneous Coronary Intervention
by: Mohammad Rouzbahani, et al.
Published: (2022)